White Papers

2021 FOCUS Year in Review

In 2021 FOCUS had its most successful year. We saw tremendous growth in the number of transactions we completed as well as the revenue we generated. We invite you to read our Year In Review.

White Paper: Understanding Investor Interest in Home Healthcare and Hospice

A must read for Home Healthcare and Hospice Agency Owners. We examine the key factors that have come together like a perfect storm to create the major industry consolidation currently underway. A unique window of opportunity now exists where eager buyers and motivated sellers can complete win/win deals. Private equity firms and strategic investors are interested in acquiring agencies to expand their home healthcare and hospice businesses at the same time sellers are dealing with the operational challenges created by the recent shift to the Patient Driven Grouping Model. This has led to a record level of deal activity during the first eight months of 2021.

White Paper: Can the  U.S. Bring Semiconductor Manufacturing Back to its Shores (and Should It)?

It's no secret that the U.S. has lost millions of jobs over the last three decades, about five million jobs since 2000. The U.S. used to dominate manufacturing of cars, electronics, textiles and other products. Both low and high tech manufacturing jobs have been relocating to mostly Asian countries, especially China. Although this has been an important issue for decades, it has taken on added importance recently due to three main events ...

White Paper: Behavioral Health has Captured the Interest of Private Equity

The first quarter of 2021 delivered 38 reported behavioral health transactions, an increase over any quarter in 2020. We expect some of this activity reflects deals that were delayed due to COVID-19. However, we generally expect high deal flow throughout 2021, supported by increasing private equity interest, a favorable government, and a seller pool that is ready to transact.

White Paper: The Physician’s Guide to Private Equity Transactions – June 2021

Designed to help physician owners considering a sale to private equity, this paper examines the key questions common to our initial client conversations. The learnings apply to all practice verticals from ophthalmology .. to gastroenterology .. to dermatology. Topics include: The Best Time to Sell, Determining the Best Buyer, The Private Equity Investment Model, Calculating Adjusted EBITDA for Medical Practices, Practice Valuation and Multiples, How to Get Associate Physicians to Buy-in.

Salesforce Market Insights

Salesforce Partners: A Compelling M&A Opportunity

The M&A market for companies in the Salesforce Partners program is reaching a critical inflection point. Competition is growing more intense, as the number of available firms shrinks, raising already-high valuations for those that remain independent. At the same time, proposed capital gains tax hikes make it imperative for potential sellers to consider doing deals as soon as possible.

ServiceNow Market Insights

ServiceNow Partners and the Industry Solutions Model

In the short 10 months since ServiceNow announced the expansion of its partner program and industry-aligned solutions in May 2020, Partners have benefited from rapid growth in the ServiceNow category. Furthermore, as most IT projects move to a virtual environment in the post-COVID-19 era, ServiceNow has emerged as the preferred IT service management (ITSM) platform for enterprise IT departments.

White Paper: Private Equity Investment in Ophthalmology – August 2020 State of the Market

A comprehensive view of ophthalmology's recovery from the pandemic shutdown. We review changes in elective surgery, the emerging investor interest in retina practices, private  equity acquisition activity, geographic development, and changes to acquisition practice size. As the COVID-19 fog begins to clear, we see significant near-term promise and a potential return to record deal levels.